04:51 PM EST, 11/27/2024 (MT Newswires) -- Marker Therapeutics ( MRKR ) filed a registration statement Wednesday for the potential sale of up to $300 million of securities from time to time in one or more offerings.
The filing covers the sale of the company's common and preferred shares, debt securities and warrants.
Proceeds from the offering will be used for working capital, capital expenditures and general corporate purposes, according to the company.